Article Text

Download PDFPDF
Grappling with the granuloma: where is the ACE in the hole?
  1. Andrew Bush1,2,3,
  2. Rishi Pabary3
  1. 1Centre for Paediatrics and Child Health, National Heart and Lung Institute, Imperial College London, London, UK
  2. 2Department of Paedatric Respiratory Medicine, National Heart and Lung Institute, Imperial College London, London, UK
  3. 3Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK
  1. Correspondence to Dr Andrew Bush, Royal Brompton Hospital, London SW3 6NP, UK; a.bush{at}imperial.ac.uk

Statistics from Altmetric.com

The finding of granulomas on paediatric tissue biopsy is non-specific, with a wide differential diagnosis that includes chronic infection (eg, tuberculous, atypical Mycobacterium infection, leprosy, Lyme disease, brucellosis, syphilis and histoplasmosis), immunodeficiency (hyper-IgM syndrome, chronic granulomatous disease), connective tissue disease (juvenile chronic arthritis) and miscellaneous conditions such as Blau’s syndrome, Melkersson-Rosenthal syndrome, Anderson-Fabry disease and Vogt-Koyanagi-Harada syndrome. Tumours such as hepatoblastoma and neuroblastoma may also provoke a granulomatous reaction.1 Another important differential is sarcoidosis which, like many of the above, is rare in children and has a wide clinical spectrum of severity. Older children with sarcoidosis usually have a presentation similar to adults, with frequent hilar lymphadenopathy and pulmonary infiltrates. Early-onset sarcoidosis, usually presenting before the age of four, is more frequently characterised by uveitis, rash and arthritis2 and one could question whether the two diseases are really the same entity.

Unlike some of the other conditions associated with granulomas, there is no specific diagnostic test for sarcoidosis. An elevated serum ACE is supportive but non-specific and there are cases diagnosed as sarcoidosis with no serum abnormality. Given that there is no gold-standard diagnosis test for sarcoidosis, and that sarcoidosis is likely an umbrella term under which lurk several different disease entities, how can we hope to make progress towards finding a specific cause, when the first prerequisite towards achieving this is to assemble a large cohort? Even …

View Full Text

Footnotes

  • Contributors AB wrote the first draft, both authors reviewed and take responsibility for the final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Brief communication
    Nadia Nathan Marie-Emeline Montagne Odile Macchi Paul-André Rosental Simon Chauveau Florence Jeny Lucile Sesé Rola Abou Taam Manon Brocvielle Jacques Brouard Mickaël Catinon Catherine Chapelon-Abric Fleur Cohen-Aubart Christophe Delacourt Céline Delestrain Antoine Deschildre Antoine Dossier Ralph Epaud Julien Haroche Véronique Houdouin Dominique Israel-Biet Karine Juvin Sylvain Le Jeune Francois Lionnet Ulrich Meinzer Marie Mittaine Hilario Nunes Sarah Mattioni Jean-Marc Naccache Marie-Hélène Odièvre Michel Vincent Annick Clement Dominique Valeyre Catherine Cavalin